Phase 3 randomized double-blind controlled trial of Cabozantinib (XL 184) vs Mitoxantrone plus Prednisone in men with previously treated symptomatic castration-resistant prostate cance (XL 184-306)

  • Parente, Phillip (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/05/1330/11/13